Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease
Objectives. The aim of this study was to investigate the effects of compound C on an in vivo mouse model of high-fat diet- (HFD-) induced obesity and hepatosteatosis. Methods. C57BL/6 mice were fed with a standard diet (n = 5) for 16 weeks and then injected saline once a day for 4 weeks as the norma...
Saved in:
| Main Authors: | Fang Wang, Yuxing Liu, Jingjing Yuan, Wenjun Yang, Zhaohui Mo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2019/3206587 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences in Fatty Acid Metabolism between MCDD and HFD Induced Metabolic Dysfunction-associated Fatty Liver Disease Model Mice
by: Jia-Xuan Wang, et al.
Published: (2025-04-01) -
Features of nonalcoholic fatty liver disease pharmacotherapy in patients with overweight and obesity
by: K. V. Pivtorak
Published: (2017-08-01) -
Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01) -
Metabolomics of Mice with Type 2 Diabetes and Nonalcoholic Fatty Liver Treated by Acupuncture
by: Yihui Guo, et al.
Published: (2024-01-01) -
Biomarkers in Nonalcoholic Fatty Liver Disease
by: Manuela G Neuman, et al.
Published: (2014-01-01)